Maintenance Medications and Supplements for Menopause
For moderate to severe menopausal symptoms, menopausal hormone therapy (MHT) remains the most effective treatment, but non-hormonal pharmacologic options should be tried first in most women due to safety considerations. 1
Initial Assessment
Before initiating treatment, evaluate for alternative medical causes of symptoms:
- Check thyroid function and screen for diabetes before attributing symptoms to menopause 1
- Laboratory testing may include estradiol, FSH, LH, and prolactin as clinically indicated 1
- Note: FSH is unreliable in women with prior chemotherapy, pelvic radiation, or those taking tamoxifen 1
- Perform pelvic examination for women complaining of vaginal dryness to assess for vaginal atrophy 1
First-Line Non-Hormonal Pharmacologic Options
For Vasomotor Symptoms (Hot Flashes/Night Sweats)
Antidepressants are the preferred first-line prescription option:
- Venlafaxine (SNRI): Effective for reducing hot flash frequency and severity 2, 1
- Paroxetine (SSRI): Demonstrated efficacy but avoid in women taking tamoxifen due to CYP2D6 inhibition that reduces tamoxifen effectiveness 1
- Fluoxetine (SSRI): Shown to be effective 3
- Doses are typically lower than those used for depression 1
Anticonvulsants:
- Gabapentin: Effective for reducing hot flash frequency and severity 2, 1, 3
- Pregabalin: Also shown efficacy 1
Antihypertensives:
For Vaginal Dryness and Dyspareunia
Non-hormonal vaginal treatments:
- Water-based lubricants and moisturizers are primary first-line treatments 1
- Silicone-based products may last longer than water-based or glycerin-based alternatives 1
- Vaginal dilators or pelvic floor relaxation techniques for dyspareunia 1
Lifestyle Modifications
Weight loss of ≥10% may eliminate hot flash symptoms 1
Smoking cessation improves frequency and severity of hot flashes 1
Limit alcohol intake if it triggers hot flashes in individual patients 1
Cognitive behavioral therapy (CBT) reduces the perceived burden of hot flashes 1
Physical activity is recommended for overall health, though direct evidence for vasomotor symptom improvement is limited 1
Menopausal Hormone Therapy (MHT)
MHT is the most effective treatment for vasomotor symptoms but should be reserved for moderate to severe symptoms unresponsive to non-hormonal options 1, 4, 5, 6, 7, 3
Formulation Selection
For women with an intact uterus:
- Combination estrogen plus progestogen is required to prevent endometrial cancer 2, 1, 4, 7
- Micronized progestin is preferred over medroxyprogesterone acetate (MPA) due to lower rates of VTE and breast cancer risk 2
- Alternative: Estrogen combined with bazedoxifene (a SERM) for women who cannot tolerate progestogens 2, 4, 7
For women without a uterus:
Route of Administration
Transdermal estrogen formulations are preferred over oral due to lower rates of venous thromboembolism and stroke 2
Available formulations include oral, transdermal patches, vaginal rings, and intrauterine devices 2
Dosing Principles
Use the lowest effective dose for the shortest duration to control symptoms 2, 4
Treatment should be individualized based on patient-specific risks and requires specialist management 2, 1
Absolute Contraindications to MHT
- History of hormone-related cancers (breast, endometrial) 2, 1
- History of abnormal vaginal bleeding 2, 1
- Active or recent thromboembolic event 2
- Pregnancy 2, 1
- Active liver disease 2, 1
Use with Caution
Special Populations
Young women with premature menopause:
- Consider oral contraceptives or MHT for symptom relief and potential cardiac and bone benefits if not contraindicated 2, 1
Local Vaginal Estrogen Therapy
For isolated vaginal symptoms:
- Low-dose vaginal estrogen (tablets, rings, creams) are effective for vaginal atrophy and dryness 2, 1
- Results take 6-12 weeks to become apparent 1
- Safety in women with breast cancer history is not well established 1
- Not recommended for women on aromatase inhibitors 1
- Evidence suggests local estrogen does not increase breast cancer recurrence risk 2
Supplements and Alternative Therapies
Vitamin E and D:
- Topical vitamin D or E may help with vaginal dryness 2
Soy products:
- Modest improvement in hot flashes and vaginal dryness suggested by one systematic review 4
- Insufficient evidence for isoflavone supplements from soy or red clover 3
Black cohosh:
- Insufficient clinical trial evidence to support or refute efficacy 3
- No serious side effects with short-term use 3
Not recommended due to lack of efficacy:
- Dong quai, evening primrose oil, ginseng, Chinese herbal mixtures, acupuncture, magnet therapy showed no benefit in clinical trials 3
- Yoga, paced respiration, exercise, stress reduction, relaxation therapy, omega-3 fatty acids, botanical products lack high-quality consistent evidence 4
What NOT to Use
Custom-compounded bioidentical hormones are NOT recommended as data supporting claims of superior safety or effectiveness compared to standard hormones are lacking 2, 1
Tibolone should be avoided as it may increase breast cancer recurrence risk 2
Common Pitfalls
Avoid paroxetine in women taking tamoxifen due to drug interaction that reduces tamoxifen efficacy 1
Do not rely on FSH levels in women with prior chemotherapy, pelvic radiation, or those on tamoxifen for determining menopausal status 1
Refer to appropriate specialists for MHT dosing and management rather than attempting complex hormone management in primary care 2, 1